GenScript teams with Mimulus for massive DNA output
GenScript announced a partnership with Mimulus to scale industrial DNA synthesis toward millions‑to‑billions of oligos per chip, positioning the capability for high‑volume applications including DNA data storage. The collaboration signals growing upstream supply options for large‑scale sequence requirements. (x.com)
DNA is being pitched as a storage medium for cold data, and GenScript said on April 9 it will work with Mimulus to scale the DNA writing step from millions to billions of short sequences on one chip. (genscript.com) In DNA data storage, software turns digital files into strings of the four DNA letters, then manufacturers synthesize those strings as short fragments called oligonucleotides. Reviews in *Nature Reviews Genetics* and *Chemical Society Reviews* describe synthesis as the main writing bottleneck for the field. (nature.com, pubs.rsc.org) GenScript said the partnership is a multi-year collaboration with Los Angeles-based Mimulus, and that its current manufacturing platform can already synthesize 8 million oligonucleotides in parallel. GenomeWeb reported the companies are targeting parallel output in the billions on a single chip. (genscript.com, genomeweb.com) Mimulus said GenScript will supply the high-throughput DNA synthesis needed to mass-produce its Glacier Data Storage Cards, which it describes as part of a “Molecular Archive” system that uses no electricity to preserve data once encoded. The companies said they are aiming for cost gains by 2030. (prnewswire.com, prnewswire.com) The pitch lands as technology companies keep looking for cheaper long-term archive systems for data that is rarely accessed but must be kept for years. Microsoft Research says its DNA storage work is focused on archival use, not everyday computing storage. (microsoft.com) The basic attraction is density and durability. Twist Bioscience says DNA is being developed to fill the gap in archival storage, while a 2024 review in *Frontiers of Chemical Science and Engineering* said DNA offers very high storage density and long durability compared with flash memory and hard drives. (twistbioscience.com, link.springer.com) The harder part is writing data cheaply enough. A 2020 *Nature Communications* paper said the cost and speed of synthesis were the “current bottleneck” for DNA storage systems, and newer reviews still point to throughput, error rates, and solvent-heavy chemistry as limits on scale. (nature.com, link.springer.com) That is why the GenScript-Mimulus deal reads less like a consumer product launch and more like an upstream manufacturing play. If GenScript can move from 8 million parallel oligos today to billions per chip, suppliers for DNA storage would have a larger writing pipeline than most public projects have described so far. (genomeweb.com, genscript.com) The field is still crowded with technical and commercial unknowns. Microsoft, Twist Bioscience, Illumina, Western Digital and others formed a DNA Data Storage Alliance in 2020, and Twist’s storage effort was later spun out as Atlas Data Storage, showing companies are still testing different routes to commercialization. (businesswire.com, orrick.com) For now, the clearest new fact is not that DNA storage has arrived at scale, but that another large synthesis supplier is trying to build the factory layer behind it. GenScript and Mimulus put a date on that effort: April 9, 2026. (genscript.com, prnewswire.com)
